These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16377688)

  • 1. Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia.
    Olsen KM; Gentry-Nielsen M; Yue M; Snitily MU; Preheim LC
    Antimicrob Agents Chemother; 2006 Jan; 50(1):210-9. PubMed ID: 16377688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia.
    Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry MJ
    Alcohol Clin Exp Res; 1999 May; 23(5):842-9. PubMed ID: 10371404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
    Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry-Nielsen MJ
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):103-11. PubMed ID: 15698715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia.
    Gentry-Nielsen MJ; Olsen KM; Preheim LC
    Antimicrob Agents Chemother; 2002 May; 46(5):1345-51. PubMed ID: 11959567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with protein-conjugated and native type 3 capsular polysaccharide in an ethanol-fed rat model of pneumococcal pneumonia.
    Henriksen JL; Preheim LC; Gentry MJ
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1630-7. PubMed ID: 9438523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
    Xuan D; Zhong M; Mattoes H; Bui KQ; McNabb J; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
    Ellbogen MH; Olsen KM; Gentry-Nielsen MJ; Preheim LC
    J Antimicrob Chemother; 2003 Jan; 51(1):83-91. PubMed ID: 12493791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
    LaPlante KL; Rybak MJ; Tsuji B; Lodise TP; Kaatz GW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1315-20. PubMed ID: 17296740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced hypothermia is protective in a rat model of pneumococcal pneumonia associated with increased adenosine triphosphate availability and turnover*.
    Beurskens CJ; Aslami H; Kuipers MT; Horn J; Vroom MB; van Kuilenburg AB; Roelofs JJ; Schultz MJ; Juffermans NP
    Crit Care Med; 2012 Mar; 40(3):919-26. PubMed ID: 22036856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
    Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
    J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of survival and pharmacodynamic relationships for five fluoroquinolones in a neutropenic murine model of pneumococcal lung infection.
    Ernst EJ; Klepser ME; Petzold CR; Doern GV
    Pharmacotherapy; 2002 Apr; 22(4):463-70. PubMed ID: 11939681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct examination and cultures of bronchoalveolar lavage in pneumonia diagnosis: a comparative experimental study.
    Brandão da Silva N; Martins L; Martins F; Anflor J; Tonietto T; Koefender C; Cardoso PG; Moreira J
    Intensive Care Med; 2007 Oct; 33(10):1840-7. PubMed ID: 17673974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
    Azoulay-Dupuis E; Bédos JP; Mohler J; Moine P; Cherbuliez C; Peytavin G; Fantin B; Köhler T
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1046-54. PubMed ID: 15728901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ethanol ingestion on killing of Streptococcus pneumoniae, Staphylococcus aureus and Staphylococcus epidermidis by rat neutrophils.
    Jareo PW; Preheim LC; Lister PD; Gentry MJ
    Alcohol Alcohol; 1995 May; 30(3):311-8. PubMed ID: 7545985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of pneumococcal pneumonia in chronically intoxicated rats.
    Davis CC; Mellencamp MA; Preheim LC
    J Infect Dis; 1991 Apr; 163(4):799-805. PubMed ID: 2010633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol impairs neutrophil chemotaxis in vitro but not adherence or recruitment to lungs of rats with experimental pneumococcal pneumonia.
    Lister PD; Gentry MJ; Preheim LC
    J Infect Dis; 1993 May; 167(5):1131-7. PubMed ID: 8517883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
    Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
    Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.